| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 7 B
Yang J et al. (2020)
|
Xla Wt + xbp1 + DEX
NF42 (immunohistochemistry)
|
|
|
|
|
Fig. 7 A
Yang J et al. (2020)
|
Xla Wt + xbp1 + DEX
NF42 (in situ hybridization)
|
|
|
|
Fig. 3 ABCD
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF10 (in situ hybridization)
|
|
|
|
Fig. 5 A
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF37/38 (in situ hybridization)
|
|
|
|
|
Fig, 5 B
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF37/38 (RT-PCR)
|
|
|
|
Fig. 4. AB
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF42 (immunohistochemistry)
|
|
|
|
Fig 7 B D
Yuan L et al. (2014)
|
Xla Wt + xbp1 MO
NF 43
|
|
|